SCHEMBL7334665

SCHEMBL7334665

CCC(C(=O)O)C(C)CBr

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
ACE P12821 2/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
CHRM1 P11229 1/20 0.37
AKR1A1 P14550 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
SLC1A3 P43003 2/20 0.35
SLC1A2 P43004 2/20 0.35
SLC1A1 P43005 2/20 0.35
MME P08473 1/20 0.34
CPA1 P15085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11369383 1.00 ALDH1A1 (0.39) ALDH1A1ACETSHRTDP1CHRM1
SCHEMBL27984989 0.87 ACE (0.46) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL25847046 0.87 ACE (0.46) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL13040584 0.87 ACE (0.46) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL2944717 0.87 ACE (0.46) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL12260419 0.87 ACE (0.46) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL11365177 0.78 TDP1 (0.39) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL11365181 0.78 TDP1 (0.39) ALDH1A1ACETDP1CHRM1AKR1A1
SCHEMBL277403 0.76 CHRM1 (0.54) ALDH1A1TSHRTDP1CHRM1AKR1A1
SCHEMBL606891 0.76 ALDH1A1 (0.39) ALDH1A1TSHRTDP1CHRM1AKR1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825184-B1 Heterocyclic derivatives as platelet aggregation inhibitors ASTRAZENECA AB (SE) 2001-06-20 EP disclosed
EP-0691959-B1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LTD (GB) 1998-07-22 EP disclosed
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed
US-5728701-A INHIBIT PLATELET AGGREGATION ZENECA LIMITED (GB) 1998-03-17 US disclosed
EP-0825184-A1 Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LIMITED (GB) 1998-02-25 EP disclosed
US-5652242-A 3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BURYIC ACID, AMIDE OR ESTER; INHIBITORS OF BINDING OF FIBRINOGEN TO GLYCOPROTEIN ZENECA LIMITED (GB) 1997-07-29 US disclosed
US-5563141-A INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION ZENECA LIMITED (GB) 1996-10-08 US disclosed
US-5556977-A ANTIAGGLOMERANTS FOR CELLS, ANTICOAGULANTS, ANTIISCHEMIC AGENTS USING PYRIDINYLPIPERAZINE DERIVATIVES ZENECA LIMITED (GB) 1996-09-17 US disclosed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 EP disclosed
EP-0690847-A1 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-10 EP disclosed
WO-1994022835-A2 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed
US-4305876-A CULTURE PRODUCT INTERMEDIATE IN THE PREPARATION OF VITAMINS E AND K HOFFMANN-LA ROCHE, INC. (US) 1981-12-15 US disclosed
US-4138289-A ASYMMETRIC HYDROGENATION BY MICROORGANISM, FERMENTATION HOFFMANN-LA ROCHE INC. (US) 1979-02-06 US disclosed